The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options.
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Find out more about Idorsia's strategy, clinical development pipeline, and the story of how Idorsia was born.
Idorsia has an experienced team of highly qualified professionals who are all reaching out for more.
Idorsia development compounds target a number of different diseases.